As of 2024-12-13, the EV/EBITDA ratio of Dechra Pharmaceuticals PLC (DPH.L) is
18.62.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DPH.L's latest enterprise value
is 4,831.43 mil GBP. DPH.L's TTM EBITDA according to its financial statements is
259.50 mil GBP. Dividing these 2
quantities gives us the above DPH.L EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
6.3x - 8.8x |
7.6x |
| Forward P/E multiples |
10.9x - 11.9x |
11.4x |
| Fair Price |
360.22 - 1,637.18 |
879.02 |
| Upside |
-90.7% - -57.7% |
-77.3% |